Efficacy of gastrointestinal medications in patients with upper gastrointestinal symptoms -randomized, parallel group, open-label study- - Efficacy of gastrointestinal medications in patients with upper gastrointestinal symptoms

Japan Dyspepsia Society0 sites500 target enrollmentApril 8, 2011

Overview

No summary available.

Registry

who.int

Start Date

April 8, 2011

End Date

June 1, 2008

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Japan Dyspepsia Society

•(1\) Patients who have alarm symptoms, such as vomiting, gastrointestinal bleeding or acute weight loss requiring endoscopy. (2\) Patients who are judged by the investigator to require a prompt endoscopy. (3\) Patients who have a confirmed or suspected malignant lesion. (4\) Patients who have prior gastrointestinal resection or vagotomy. (5\) Patients with irritable bowel syndrome. (6\) PPIs, H2\-receptor antagonists, prokinetic agents, gastric mucosal protective agents, anticholinergics, antidepressants, anxiolytics, steroids (other than topical steroids), non\-steroidal anti\-inflammatory drugs, aspirin or bisphosphonates were discontinued at least 1 week before study entry and were not allowed during the study period. (7\) Patients who are judged to be ineligible for study entry due to serious hepatic, renal, or cardiac disease. (8\) Patients who might possibly be pregnant or were lactating. (9\) Patients who are judged to be ineligible for study entry by the investigator.